Form 4: PAVmed Inc. Director Ronald Sparks Acquires Shares

PAVmed Inc. reports that Director Ronald M. Sparks acquired 13,930 shares of common stock on April 2, 2026, as part of a restricted stock grant.

Summary

• Ronald M. Sparks, a Director at PAVmed Inc., acquired 13,930 shares of common stock on April 2, 2026.
• The acquisition was made through a restricted stock grant under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan.
• These shares have a single vesting date of May 20, 2029, and are subject to forfeiture if the requisite service period is not completed.
• Following this transaction, Mr. Sparks beneficially owns 21,097 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider share acquisition is generally positive, the nature of restricted stock with a distant vesting date and forfeiture conditions tempers immediate positive sentiment.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The grant of restricted stock aligns management and director incentives with long-term shareholder value.

Negatives

• The shares are subject to forfeiture, indicating performance or service conditions are attached.
• The vesting date is several years away (May 20, 2029), suggesting a long-term commitment is required.

Risks

• The restricted stock is subject to forfeiture if the requisite service period is not completed, posing a risk to the reporting person's ownership.
• Future performance of PAVmed Inc. could impact the ultimate value and retention of these shares.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a transaction of restricted stock.

Industry Context

StockSavvy.ai notes that insider transactions, particularly the acquisition of shares by directors, are closely watched by the market as potential indicators of management's belief in the company's valuation and future performance within the healthcare technology sector.

Stakeholder Impact

• Shareholders: May view director share acquisition positively, potentially signaling confidence in the company's long-term value.
• Employees: The structure of the incentive plan may influence employee retention and motivation.
• Management/Directors: The restricted stock grant aligns their interests with long-term company performance, subject to service conditions.

Next Steps

• The reporting person must complete the requisite service period to avoid forfeiture of the restricted stock.
• The shares will vest on May 20, 2029.

Key Dates

Keywords

PAVmed Inc., PAVM, Form 4, Insider Trading, Restricted Stock, Equity Incentive Plan, Director Compensation, Share Acquisition